Technology
Latest News
Advertisement
Advertisement
April 25, 2016.
April 19, 2016.
Pharmaceutical Executive
April 18, 2016.
April 13, 2016.
More than a year after approving its first biosimilar, FDA has authorized a second therapy in this category.
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last week, it was difficult to be pessimistic, writes Bill Drummy.
March 31, 2016.
March 31, 2016.
March 29, 2016.
Pharmaceutical Executive
March 23, 2016.
Pharmaceutical Executive
March 18, 2016.
Pharm Exec talks value-based healthcare with Professor Bengt Jönsson of the Stockholm School of Economics.
Pharmaceutical Executive
March 11, 2016.
March 10, 2016.
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5